🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an open-label, long-term safety study of HPN-100 (RAVICTI; glycero...
Status
Completed
Location
UCLA Pediatrics/Genetics
Start Date
2010-10-04
Trial ID
NCT01257737
Treatments Being Tested
Urea cycle disorders are inherited illnesses in which the body does not pro...
Status
Completed
Location
Baylor College of Medicine
Start Date
2008-02
Trial ID
NCT00345605
Treatments Being Tested
This is a randomized, controlled, open-label parallel arm study to assess t...
Status
Completed
Location
University of Florida (UF) - Shands Hospital
Start Date
2018-02-20
Trial ID
NCT03335488
The purpose of this study is to determine whether HPN-100 is safe and toler...
Status
Completed
Location
University of Minnesota
Start Date
2007-10
Trial ID
NCT00551200
This non-randomized, open-label study was approximately one year in duratio...
Status
Completed
Location
UCLA Pediatrics/Genetics
Start Date
2011-07
Trial ID
NCT01347073
Treatments Being Tested
To determine the safety and tolerability of single oral doses of HPN-100 as...
Status
Completed
Location
Medical Sanitary Division #2
Start Date
2005-03
Trial ID
NCT00977600
This was a long-term safety study HPN-100 in urea cycle disorder (UCD) subj...
Status
Completed
Location
Long Beach Memorial
Start Date
2009-11
Trial ID
NCT00947297
Treatments Being Tested
This was a randomized, active-controlled, double-blind, cross-over study de...
Status
Completed
Location
Long Beach Memorial
Start Date
2009-10
Trial ID
NCT00992459
Treatments Being Tested
Protocol HPN-100-005 was the first study of HPN-100 in pediatric subjects w...
Status
Completed
Location
UCLA
Start Date
2010-03
Trial ID
NCT00947544
The purpose of this study is to determine the safety and tolerability of GT...
Status
Completed
Location
National University of Pharmacy
Start Date
2006-09
Trial ID
NCT00986895
Treatments Being Tested